Filing Details

Accession Number:
0001104659-25-012094
Form Type:
13G Filing
Publication Date:
2025-02-11 19:00:00
Filed By:
Dorset Management
Company:
Calumet Specialty Products Partners L.p. (NASDAQ:CLMT)
Filing Date:
2025-02-12
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Knott David M Jr 0 0 0%
Dorset Partners LLC 0 0 0%
KNOTT PARTNERS LP 0 0 0%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Amounts for Common Units set forth in Rows 5 through 9 and 11 above reflect the following: on July 10, 2024, in connection with the corporate reorganization of the Issuer, pursuant to which the Issuer converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Issuer, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, those Common Units were terminated in full in exchange for common stock of Calumet, Inc.


SCHEDULE 13G



Comment for Type of Reporting Person:  Amounts for Common Units set forth in Rows 5 through 9 and 11 above reflect the following: on July 10, 2024, in connection with the corporate reorganization of the Issuer, pursuant to which the Issuer converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Issuer, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, those Common Units were terminated in full in exchange for common stock of Calumet, Inc.


SCHEDULE 13G



Comment for Type of Reporting Person:  Amounts for Common Units set forth in Rows 5 through 9 and 11 above reflect the following: on July 10, 2024, in connection with the corporate reorganization of the Issuer, pursuant to which the Issuer converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Issuer, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, those Common Units were terminated in full in exchange for common stock of Calumet, Inc.


SCHEDULE 13G


 
Knott David M Jr
 
Signature:/s/ David M. Knott, Jr.
Name/Title:David M. Knott, Jr.
Date:02/12/2025
 
Dorset Partners LLC
 
Signature:/s/ David M. Knott, Jr.
Name/Title:David M. Knott, Jr./ Executive Managing Member
Date:02/12/2025
 
KNOTT PARTNERS LP
 
Signature:/s/ David M. Knott, Jr.
Name/Title:By: Knott Partners Management, LLC, as general partner, David M. Knott, Jr./ Executive Managing Member
Date:02/12/2025